ExploreWatchlistsPricing
  1. JP-listed companies
  3. Financials
  4. Stockholders' equity

(4881)

Market cap
¥2.9B
P/E ratio
Funpep develops new medicines using functional peptides and its STEP UP drug discovery platform, focusing on treatments like SR-0379 for skin ulcers.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Dec 31, 20251,464-42.53%
Dec 31, 20242,547+10.67%
Dec 31, 20232,302-14.58%
Dec 31, 20222,695-15.16%
Dec 31, 20213,176-11.00%
Dec 31, 20203,569+283.42%
Dec 31, 2019931-20.17%
Dec 31, 20181,166+62.70%
Dec 31, 2017717

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat